Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas


Purpose:

This single ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX003 in approximately 40 healthy subjects.


Criteria:

Inclusion Criteria: - Healthy subjects - Body mass index (BMI) between 18-32 kg/m2 with a minimum weight of 45 kg - Female subjects must be surgically sterile or post-menopausal or if of child-bearing potential must use contraception - Male subjects and their partners of childbearing potential must use contraception Exclusion Criteria: - Positive test for drug of abuse - Past or current history of alcohol abuse - Positive for TB, hepatitis B, hepatitis C or HIV infection


NCT ID:

NCT02458677


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

San Antonio, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.